Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_s1.htm |
| EX-23.2 - EXHIBIT 23.2 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex23-2.htm |
| EX-10.50 - EXHIBIT 10.50 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-50.htm |
| EX-10.12 - EXHIBIT 10.12 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-12.htm |
| EX-10.51 - EXHIBIT 10.51 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-51.htm |
| EX-10.52 - EXHIBIT 10.52 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-52.htm |
| EX-10.38 - EXHIBIT 10.38 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-38.htm |
| EX-10.39 - EXHIBIT 10.39 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-39.htm |
| EX-10.37 - EXHIBIT 10.37 - BRAINSTORM CELL THERAPEUTICS INC. | v245401_ex10-37.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated March 30, 2011 relating to the financial statements of BRAINSTORM CELL THERAPEUTICS INC. appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to us under the headings "Experts" in such Prospectus.
/s/ Brightman Almagor Zohar & Co.
Brightman Almagor Zohar & Co.
A member of Deloitte Touche Tohmatsu
Tel Aviv, Israel
February 2, 2012